A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23

Medicine & Life Sciences

• anillin 100%
• Kinesin 71%
• Drive 57%
• Hepatocellular Carcinoma 45%
• Growth 28%
• Tumor Microenvironment 8%
• Proteins 7%
• Farnesyl-Diphosphate Farnesyltransferase 7%
• Neoplasms 6%
• Sterol Regulatory Element Binding Protein 2 6%
• farnesyl pyrophosphate 6%
• Cholesterol 6%
• Programmed Cell Death 1 Receptor 6%
• Guide RNA 5%
• Beauty 5%
• Diethylnitrosamine 5%
• Cell Proliferation 5%
• 3-hydroxy-3-methylglutaryl-coenzyme A 5%
• Dependovirus 5%
• Sorafenib 5%
• Clustered Regularly Interspaced Short Palindromic Repeats 4%
• RNA Sequence Analysis 4%
• Chromatin Immunoprecipitation 4%
• Survival 4%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 4%
• Oxidoreductases 3%
• Serogroup 3%
• Therapeutics 3%
• Psychological Inhibition 3%
• Genes 3%
• Cell Death 3%
• Transcription Factors 3%
• Ligands 3%
• Mortality 2%